submit urlsubmit rss feedadd directoryphysician directoryPharmacology opportunity

article

Amprenavir (Agenerase®) is a protease inhibitor used to treat HIV. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200mg, delivered in eight very large gel capsules. Production of amprenavir was discontinued by the manufacturer December 31, 2004.


More on [ Amprenavir ]


directory of related categories

 
Amprenavir RSS feed
Subscribe to Amprenavir RSS feed

directory of related sites

Agenerase Consumer Information - FDA - Consumer FAQ in html format with a link to approved labeling in pdf format.

MedlinePlus: Amprenavir - Features information about dosage, usage, warnings, and side effects.
Meta Description: [ Amprenavir ]

Amprenavir related videos
Yes, it's a woman!
Next Video
Amprenavir related videos

 

HOMEADVERTISINGABOUT US

articlesartsbusinesscomputersgameshealthhospitalshomekids & teensnewsmobilephysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld


Submit a Site About Become an Editor